Condition
Dermatologic Diseases
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00001505Completed
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00842283RecruitingPrimary
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
NCT00001506CompletedPrimary
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT04668846UnknownPrimary
A Sample Collection Study Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits
NCT03913598CompletedPrimary
Internet and Social Media Use in Dermatology Patients
Showing all 5 trials